fluindione has been researched along with Budd-Chiari Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoun, O; Barruet, R; Ficko, C; Imbert, P; Méchaï, F; Rapp, C | 1 |
| Bouyabrine, H; Hamoui, M; Navarro, F; Panaro, F; Wolf, P | 1 |
2 other study(ies) available for fluindione and Budd-Chiari Syndrome
| Article | Year |
|---|---|
Budd-Chiari syndrome as a vascular complication of amebic liver abscess.
Topics: Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Budd-Chiari Syndrome; Enoxaparin; Humans; Liver Abscess, Amebic; Male; Metronidazole; Ofloxacin; Phenindione | 2009 |
Fluindione: a francophone oral anticoagulant drug utilized in liver transplant recipients for Budd-Chiari syndrome.
Topics: Administration, Oral; Anticoagulants; Budd-Chiari Syndrome; Humans; Liver Transplantation; Phenindione | 2011 |